PTGX logo

Protagonist Therapeutics, Inc. (PTGX) Net Income

Annual Net Income:

$275.19M+$354.14M(+448.54%)
December 31, 2024

Summary

  • As of today, PTGX annual net profit is $275.19 million, with the most recent change of +$354.14 million (+448.54%) on December 31, 2024.
  • During the last 3 years, PTGX annual net income has risen by +$400.74 million (+319.18%).
  • PTGX annual net income is now at all-time high.

Performance

PTGX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

Quarterly Net Income:

-$34.77M-$23.12M(-198.34%)
June 30, 2025

Summary

  • As of today, PTGX quarterly net profit is -$34.77 million, with the most recent change of -$23.12 million (-198.34%) on June 30, 2025.
  • Over the past year, PTGX quarterly net income has dropped by -$4.16 million (-13.57%).
  • PTGX quarterly net income is now -116.77% below its all-time high of $207.34 million, reached on March 31, 2024.

Performance

PTGX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

TTM Net Income:

$52.04M-$4.16M(-7.39%)
June 30, 2025

Summary

  • As of today, PTGX TTM net profit is $52.04 million, with the most recent change of -$4.16 million (-7.39%) on June 30, 2025.
  • Over the past year, PTGX TTM net income has dropped by -$117.92 million (-69.38%).
  • PTGX TTM net income is now -81.09% below its all-time high of $275.19 million, reached on December 31, 2024.

Performance

PTGX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

PTGX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+448.5%-13.6%-69.4%
3Y3 Years+319.2%+15.3%+139.2%
5Y5 Years+456.5%-79.0%+180.3%

PTGX Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+316.0%-116.8%+9.6%-81.1%+137.0%
5Y5-Yearat high+316.0%-116.8%+15.3%-81.1%+137.0%
All-TimeAll-Timeat high+316.0%-116.8%+15.3%-81.1%+137.0%

PTGX Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$34.77M(-198.3%)
$52.04M(-7.4%)
Mar 2025
-
-$11.65M(-108.9%)
$56.19M(-79.6%)
Dec 2024
$275.19M(+448.5%)
$131.67M(+496.5%)
$275.19M(+61.1%)
Sep 2024
-
-$33.21M(-8.5%)
$170.85M(+0.5%)
Jun 2024
-
-$30.62M(-114.8%)
$169.95M(+4.8%)
Mar 2024
-
$207.34M(+658.5%)
$162.11M(+305.3%)
Dec 2023
-$78.95M(+38.0%)
$27.34M(+180.1%)
-$78.95M(+43.8%)
Sep 2023
-
-$34.10M(+11.3%)
-$140.48M(-2.1%)
Jun 2023
-
-$38.46M(-14.0%)
-$137.61M(+1.8%)
Mar 2023
-
-$33.73M(+1.4%)
-$140.19M(-10.0%)
Dec 2022
-$127.39M(-1.5%)
-$34.19M(-9.5%)
-$127.39M(+2.1%)
Sep 2022
-
-$31.23M(+23.9%)
-$130.11M(+1.9%)
Jun 2022
-
-$41.04M(-96.1%)
-$132.68M(-8.3%)
Mar 2022
-
-$20.93M(+43.3%)
-$122.48M(+2.4%)
Dec 2021
-$125.55M(-89.8%)
-$36.91M(-9.2%)
-$125.55M(-16.8%)
Sep 2021
-
-$33.80M(-9.6%)
-$107.53M(-32.0%)
Jun 2021
-
-$30.84M(-28.5%)
-$81.49M(-16.3%)
Mar 2021
-
-$24.00M(-27.1%)
-$70.07M(-5.9%)
Dec 2020
-$66.15M
-$18.89M(-143.3%)
-$66.15M(-2.1%)
Sep 2020
-
-$7.76M(+60.0%)
-$64.77M(+11.8%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$19.42M(+3.3%)
-$73.41M(+11.7%)
Mar 2020
-
-$20.08M(-14.7%)
-$83.16M(-7.7%)
Dec 2019
-$77.19M(-98.3%)
-$17.50M(-6.7%)
-$77.19M(-4.9%)
Sep 2019
-
-$16.41M(+43.8%)
-$73.55M(-11.6%)
Jun 2019
-
-$29.17M(-106.9%)
-$65.88M(-45.2%)
Mar 2019
-
-$14.10M(-1.7%)
-$45.37M(-16.6%)
Dec 2018
-$38.92M(-5.3%)
-$13.87M(-58.7%)
-$38.92M(-38.5%)
Sep 2018
-
-$8.73M(-0.8%)
-$28.11M(-16.2%)
Jun 2018
-
-$8.66M(-13.1%)
-$24.20M(+20.7%)
Mar 2018
-
-$7.66M(-151.0%)
-$30.52M(+17.4%)
Dec 2017
-$36.96M(+0.6%)
-$3.05M(+36.7%)
-$36.96M(+18.2%)
Sep 2017
-
-$4.83M(+67.8%)
-$45.15M(+4.8%)
Jun 2017
-
-$14.98M(-6.2%)
-$47.41M(-19.9%)
Mar 2017
-
-$14.10M(-25.4%)
-$39.53M(-6.3%)
Dec 2016
-$37.18M(-150.2%)
-$11.25M(-58.8%)
-$37.18M(-43.4%)
Sep 2016
-
-$7.08M(+0.2%)
-$25.93M(-37.6%)
Jun 2016
-
-$7.10M(+39.6%)
-$18.84M(-60.4%)
Mar 2016
-
-$11.75M(-335.6%)
-$11.75M(-335.6%)
Dec 2015
-$14.86M(-34.2%)
-
-
Mar 2015
-
-$2.70M
-$2.70M
Dec 2014
-$11.07M
-
-

FAQ

  • What is Protagonist Therapeutics, Inc. annual net profit?
  • What is the all-time high annual net income for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. annual net income year-on-year change?
  • What is Protagonist Therapeutics, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Protagonist Therapeutics, Inc. TTM net profit?
  • What is the all-time high TTM net income for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. TTM net income year-on-year change?

What is Protagonist Therapeutics, Inc. annual net profit?

The current annual net income of PTGX is $275.19M

What is the all-time high annual net income for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high annual net profit is $275.19M

What is Protagonist Therapeutics, Inc. annual net income year-on-year change?

Over the past year, PTGX annual net profit has changed by +$354.14M (+448.54%)

What is Protagonist Therapeutics, Inc. quarterly net profit?

The current quarterly net income of PTGX is -$34.77M

What is the all-time high quarterly net income for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high quarterly net profit is $207.34M

What is Protagonist Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, PTGX quarterly net profit has changed by -$4.16M (-13.57%)

What is Protagonist Therapeutics, Inc. TTM net profit?

The current TTM net income of PTGX is $52.04M

What is the all-time high TTM net income for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high TTM net profit is $275.19M

What is Protagonist Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, PTGX TTM net profit has changed by -$117.92M (-69.38%)
On this page